Speaking Engagements February 26, 2019
Boston Bar Association
16 Beacon Street
Boston, MA

CLE: Biosimilars and IP: Recent Developments in BPCIA Litigation

With the passing of the BPCIA, Congress created a new pathway for the approval of biosimilar products and, along with it, a mechanism for resolving patent disputes involving those products. This CLE will discuss recent developments in BPCIA patent litigation including the patent dance; implications of label carve-outs on induced infringement claims; economic issues pertaining to damages and irreparable harm; and antitrust considerations in the settlement of such litigation. Goodwin's Nick Mitrokostas will be a featured speaker.

For more information, please visit the event website.